In a recent development in the legal battle between biotechnology companies, Natera has formally requested that the U.S. Supreme Court dismiss CareDx’s petition seeking review of a Third Circuit decision. This decision previously overturned a $45 million jury verdict related to CareDx’s false advertising claims against Natera. CareDx argued that the Third Circuit’s ruling created…
In a critical development for patent litigation, the Federal Circuit has rejected TQ Delta’s request to revisit the damages award in its case against CommScope Holding Co. The decision, delivered on Friday, upheld the original calculation that resulted in an $11.1 million damages award for TQ Delta, thereby curtailing any possibility of a new damages…
Pfizer Inc. and Dexcel Ltd., an Israeli pharmaceutical company, have agreed to discontinue a legal battle concerning the heart drug Vyndamax. This agreement was reached just before the case was set to proceed to a bench trial. Pfizer’s legal action aimed to prevent Dexcel from manufacturing a generic version of Vyndamax, a medication designed for…
The U.S. Supreme Court is set to hear Hikma Pharmaceuticals USA v Amarin Pharma, a case delving into the intricacies of pharmaceutical patent law. The dispute centers on the interactions between Amarin, the manufacturer of the cardiovascular medication Vascepa, and Hikma Pharmaceuticals, which produces a generic substitute. At its core, this case questions the threshold…
In recent years, U.S. District Judge Alan Albright from the Western District of Texas emerged as a pivotal figure in patent litigation. Known for attracting a disproportionate number of patent cases to his courtroom, his approach triggered significant debate and mixed reactions across legal circles. While initially criticized by the Federal Circuit for concentrating patent…
U.S. District Judge Alan Albright’s impact on patent litigation has left a substantial imprint on the legal landscape. Serving in the Western District of Texas, Judge Albright rose to prominence in 2019, attracting considerable attention for his management of patent cases. His court became a sought-after venue for patent disputes, prompting discussions on judicial efficiency…
In the latest series of decisions, U.S. Patent and Trademark Office Director John Squires has issued a bulk order granting five inter partes reviews (IPRs) under the America Invents Act, while denying four others. The decisions were rendered with minimal commentary, a strategy that has become increasingly common in recent practice. This approach is part…
The Federal Circuit recently upheld the U.S. International Trade Commission’s decision in favor of Keysight Technologies Inc., absolving it of allegations made by Centripetal Networks LLC regarding patent infringement in the cybersecurity domain. This ruling includes a notable finding that invalidates several claims within one of Centripetal’s patents. The decision signals significant implications for ongoing…
The U.S. Patent and Trademark Office (USPTO) is experiencing a significant transition as its acting leader, Drew Hirshfeld, prepares to depart. His role in steering the agency’s patent division has been pivotal, and his imminent retirement marks an important shift. Hirshfeld, who stepped in as the acting commissioner, will be succeeded by a deputy commissioner…
Corcept Therapeutics Inc. is urging the full U.S. Court of Appeals for the Federal Circuit to reconsider a panel’s decision that upheld a lower court’s ruling in favor of Teva Pharmaceuticals USA Inc. regarding the production of a generic version of Korlym, a drug used to treat Cushing’s syndrome. Corcept contends that the panel improperly…
The U.S. Court of Appeals for the Federal Circuit recently delivered a significant ruling affirming that Niantic, the creator of the popular augmented reality games Pokémon Go and Harry Potter: Wizards Unite, did not infringe upon patents claimed by a company founded by biotech billionaire Patrick Soon-Shiong. The court maintained that the patents in question…
The Federal Circuit has decided not to rehear a pivotal case concerning Sony’s PlayStation controllers, effectively ending a legal battle over a claimed $500 million in damages. The patent dispute centered on allegations that Sony’s controllers infringed upon a computer input device patent. However, the court previously ruled in favor of Sony, finding no infringement…
In a recent decision, the U.S. Court of Appeals for the Federal Circuit has ordered a New York federal court to revisit a lawsuit alleging that Google and YouTube’s Content ID system infringes on a patent held by a licensing company. The ruling, issued on April 23, 2026, also affirmed the lower court’s invalidation of…
In a significant development in the ongoing patent litigation between Headwater Research LLC and Verizon Communications Inc., a Texas federal judge has ruled that Headwater cannot enforce two of its patents against Verizon due to a six-year delay in filing the lawsuit. This decision comes less than a year after a jury awarded Headwater $175…
The recent ruling by the U.S. Court of Appeals for the Federal Circuit in Willis Electric Co. Ltd. v. Polygroup Ltd. offers significant insights into the complexities of patent litigation, particularly pertaining to obviousness and damages. This verdict not only reaffirmed the validity of a single dependent claim but also upheld a substantial $42 million…
JAMS, a prominent provider of alternative dispute resolution services, has announced the addition of a retired judge from the Eastern District of Virginia, often referred to as the “Rocket Docket,” to its Washington, D.C., Resolution Center. Known for its swift handling of cases, the Eastern District of Virginia boasts a reputation for expedited judicial processes,…
Trulieve Inc., a prominent player in the cannabis industry, is embroiled in a legal battle as it contests a rival company’s patent infringement claims. This dispute has moved to a Florida federal court, where Trulieve has urged dismissal on the grounds that the complaint is devoid of factual substantiation for the alleged infringement. According to…
Norton Rose Fulbright, a prominent global law firm, is facing a $100 million lawsuit filed in Illinois state court by an advertising technology company. The company alleges that the law firm mishandled a vital patent application, leading to a significant loss of patent rights. The suit asserts that the firm’s actions resulted in the application…
The Federal Circuit on Wednesday denied Sarepta Therapeutics Inc.’s petition for a rehearing regarding a panel decision that reinstated a gene therapy patent held by the University of Pennsylvania. This patent is notably licensed by Regenxbio Inc., highlighting ongoing complexities in biotechnology patent disputes. The decision marks another chapter in the evolving landscape of gene…
RJ Reynolds Vapor Co., the company behind Vuse e-cigarettes, has initiated legal action in a Delaware federal court aiming to assert that its products do not infringe on a patent owned by competitor VPR Brands. The legal filing seeks a declaratory judgment, a proactive step in anticipation of potential intellectual property disputes that could impact…
A recent decision by a California federal court has largely upheld a lawsuit filed by Eli Lilly against a telehealth company over the compounding of its popular weight loss drugs, Mounjaro and Zepbound. While the majority of the case remains intact, the court did agree to dismiss a portion related to conspiracy claims. Eli Lilly’s…
Oura Health, a prominent Finnish company known for its smart rings that track various health metrics, has been targeted with a patent infringement lawsuit filed by Zepp Health in the Eastern District of Texas. This lawsuit forms part of a broader ongoing legal battle between the two companies over patents concerning wearable fitness technology. The…
Norton Rose Fulbright is embroiled in a significant legal challenge as an advertising technology company has filed a $100 million lawsuit in Illinois state court. The allegation centers on the assertion that the law firm mismanaged a crucial patent application, ultimately resulting in its withdrawal. More troubling is the claim that Norton Rose kept the…
Norton Rose Fulbright is currently embroiled in legal proceedings after being hit with a $100 million lawsuit stemming from an alleged mishandling of a patent application. The claim was initiated by a technology company, which accuses the global law firm of negligence leading to the denial of a vital patent by the U.S. Patent and…
In today’s complex landscape of intellectual property law, the life sciences sector faces unique challenges, especially concerning patent standing issues. The recent discourse examines these intricate elements, focusing on how mid-litigation transfers of patent ownership can affect legal standing and, subsequently, the potential for damages. Patent standing determines who is legally entitled to assert patent…